feed,title,long_url,short_url
Benzinga,"Delay Hits Humacyte's Bioengineered Human Tissue Implant For Vascular Trauma Injuries, FDA Extends Time To Review",https://benzinga.com/general/biotech/24/08/40313172/delay-hits-humacytes-bioengineered-human-tissue-implant-for-vascular-trauma-injuries-fda-extends-,https://da.gd/s1rlkk
